Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1968 1
1970 1
1971 2
1972 1
1973 1
1974 1
1978 1
1980 1
1982 1
1984 2
1985 1
1986 1
1987 2
1988 3
1989 5
1990 2
1992 4
1993 2
1994 2
1995 4
1996 1
1997 3
1998 1
1999 3
2000 7
2001 5
2002 7
2003 4
2004 9
2005 5
2006 7
2007 13
2008 11
2009 8
2010 5
2011 10
2012 10
2013 8
2014 12
2015 14
2016 12
2017 9
2018 9
2019 6
2020 13
2021 20
2022 27
2023 26
2024 16
2025 27
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

315 results

Results by year

Filters applied: . Clear all
Page 1
Immune checkpoint therapy-current perspectives and future directions.
Sharma P, Goswami S, Raychaudhuri D, Siddiqui BA, Singh P, Nagarajan A, Liu J, Subudhi SK, Poon C, Gant KL, Herbrich SM, Anandhan S, Islam S, Amit M, Anandappa G, Allison JP. Sharma P, et al. Among authors: siddiqui ba. Cell. 2023 Apr 13;186(8):1652-1669. doi: 10.1016/j.cell.2023.03.006. Cell. 2023. PMID: 37059068 Free article. Review.
The Next Decade of Immune Checkpoint Therapy.
Sharma P, Siddiqui BA, Anandhan S, Yadav SS, Subudhi SK, Gao J, Goswami S, Allison JP. Sharma P, et al. Among authors: siddiqui ba. Cancer Discov. 2021 Apr;11(4):838-857. doi: 10.1158/2159-8290.CD-20-1680. Cancer Discov. 2021. PMID: 33811120 Review.
Steroids in Immune Checkpoint Inhibitor Myocarditis.
Palaskas NL, Siddiqui BA, Deswal A. Palaskas NL, et al. Among authors: siddiqui ba. JACC CardioOncol. 2024 Aug 6;6(5):800-803. doi: 10.1016/j.jaccao.2024.07.002. eCollection 2024 Oct. JACC CardioOncol. 2024. PMID: 39479336 Free PMC article. No abstract available.
Key Regulatory Elements of the TGFβ-LRRC15 Axis Predict Disease Progression and Immunotherapy Resistance Across Cancer Types.
Storey CM, Cheng M, Altai M, Park JE, Tran J, Lueong SS, Thorek D, Mao L, Zedan W, Yuen C, Ridley A, Trajovic-Arsic M, Herrmann K, Subuhdi SK, Siddiqui BA, Lückerath K, Siveke J, Damoiseaux R, Yang X, Ulmert D. Storey CM, et al. Among authors: siddiqui ba. bioRxiv [Preprint]. 2024 Nov 25:2024.11.22.624939. doi: 10.1101/2024.11.22.624939. bioRxiv. 2024. PMID: 39651139 Free PMC article. Preprint.
Anesthesia Stages.
Siddiqui BA, Kim PY. Siddiqui BA, et al. 2023 Jan 29. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2023 Jan 29. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 32491528 Free Books & Documents.
Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer.
Khorana AA, Soff GA, Kakkar AK, Vadhan-Raj S, Riess H, Wun T, Streiff MB, Garcia DA, Liebman HA, Belani CP, O'Reilly EM, Patel JN, Yimer HA, Wildgoose P, Burton P, Vijapurkar U, Kaul S, Eikelboom J, McBane R, Bauer KA, Kuderer NM, Lyman GH; CASSINI Investigators. Khorana AA, et al. N Engl J Med. 2019 Feb 21;380(8):720-728. doi: 10.1056/NEJMoa1814630. N Engl J Med. 2019. PMID: 30786186 Clinical Trial.
Safety and Efficacy of Tarlatamab in Patients with Neuroendocrine Prostate Cancer: Results from the Phase 1b DeLLpro-300 Study.
Aggarwal R, Rottey S, Bernard-Tessier A, Mellado B, Kosaka T, Stadler WM, Horvath L, Greil R, O'Neil B, Siddiqui BA, Bauernhofer T, Bilen MA, Eskens F, Sandhu S, Shaw C, Ju CH, Decato BE, Yu B, Aparicio A. Aggarwal R, et al. Among authors: siddiqui ba. Clin Cancer Res. 2025 Sep 15;31(18):3854-3863. doi: 10.1158/1078-0432.CCR-25-1211. Clin Cancer Res. 2025. PMID: 40689871 Free PMC article. Clinical Trial.
Body composition in recurrent prostate cancer and the role of steroidogenic genotype.
Venkatesh N, Tidwell RS, Yu Y, Aparicio A, Zurita AJ, Subudhi SK, Siddiqui BA, Mukhida SS, Gregg JR, Corn PG, Koutroumpakis E, McQuade JL, Frigo DE, Pilie PG, Huff C, Logothetis CJ, Hahn AW. Venkatesh N, et al. Among authors: siddiqui ba. Endocr Relat Cancer. 2024 Oct 29;31(12):e240195. doi: 10.1530/ERC-24-0195. Print 2024 Dec 1. Endocr Relat Cancer. 2024. PMID: 39324992 Free PMC article.
Development of a leucine-rich repeat-containing protein 15-targeted radio-immunotheranostic approach to deplete pro-tumorigenic mechanisms and immunotherapy resistance.
Storey CM, Altai M, Lückerath K, Zedan W, Zhu H, Breuer L, Trajkovic-Arsic M, Park J, Hasson A, Siveke J, Abou D, Marks H, Ulmert E, Ridley A, Safi M, Lamminmäki U, Yuen C, Geres S, Mao L, Cheng M, Subudhi SK, Siddiqui BA, Federman N, Czernin J, Herrmann K, Bentolila L, Yang X, Graeber TG, Damoiseaux R, Thorek D, Ulmert D. Storey CM, et al. Among authors: siddiqui ba. Signal Transduct Target Ther. 2025 Sep 30;10(1):319. doi: 10.1038/s41392-025-02410-9. Signal Transduct Target Ther. 2025. PMID: 41022704 Free PMC article.
Continuous Androgen Deprivation Therapy with or Without Metastasis-directed Therapy for Oligometastatic Prostate Cancer: The Multicenter Phase 2 Randomized EXTEND Trial.
Sherry AD, Siddiqui BA, Haymaker C, Fellman BM, Medina-Rosales MN, Bathala TK, Wang S, Liu S, Seo A, Hara K, Lu H, Troncoso P, Chun SG, Ha CS, Mayo LL, Mok H, Park RJ, Chapin BF, Phillips RM, Deek MP, Kovitz CA, Aparicio A, Zurita AJ, Pilie PG, Cohen L, Choi SL, Reuben A, Tran PT, Corn PG, Subudhi SK, Tang C. Sherry AD, et al. Among authors: siddiqui ba. Eur Urol. 2025 Nov;88(5):496-509. doi: 10.1016/j.eururo.2025.07.006. Epub 2025 Jul 31. Eur Urol. 2025. PMID: 40750497 Clinical Trial.
315 results